Improvement Effect of Soyeom Pharmacopuncture on Gout via NLRP3 Inflammasome Regulation

• Published in: Journal of pharmacopuncture 2022-12, Vol.25 (4), p.396-403
• Main Authors: Kim, Sung Wook, Lee, Jun Ho, Kim, Hyeonjin, Lee, Seong Hoon, Jeong, Dajeong, Kim, Hyuk Soon, Lee, Cheol-Jung, Kim, Dae Yong, Yook, Tae Han, Yang, Gabsik
• Format: Article
• Language: English
• Subjects: gout; inflammasome; monosodium urate; nlrp3; Original; pharmacopuncture; soyeom
• ISSN: 2093-6966; 2234-6856
• DOI: 10.3831/KPI.2022.25.4.396

Gout is an inflammatory arthritis of the joints and soft tissues occurring due to deposition of monosodium urate (MSU) crystals, which are caused by persistent hyperuricemia. Soyeom pharmacopuncture is one treatment method that has been traditionally used for pain management in Oriental medicine. However, studies on its effect in reducing gout pain have been insufficient. Therefore, we selected Soyeom pharmacopuncture among natural products used in Korea as the new target of our study. The effects of Soyeom pharmacopuncture were examined in mouse models of acute gout induced by injection of MSU crystals into footpads. IL-1β, IL-6, and TNF-α production were examined by immunoblotting and enzyme-linked immunosorbent assay as hallmarks of NLRP3 inflammasome and cytokine activation. Soyeom pharmacopuncture reduced foot edema in gout-induced mice, as well as IL-1β, nitrite, IL-6, and TNF-α production. Moreover, Soyeom pharmacopuncture also reduced MSU-induced gout inflammatory gene expressions, specifically those in the NF-kB pathway. Pharmacopuncture may serve as a new solution for other inflammatory diseases as well. Through active follow-up studies, we could thoroughly understand the clinical value of Soyeom pharmacopuncture.